Smriti Chaudhri
Overview
Explore the profile of Smriti Chaudhri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
1
Followers
0
Related Specialties
Related Specialties
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Repurposing of Metabolic Drugs Metformin and Simvastatin as an Emerging Class of Cancer Therapeutics
Maurya S, Chaudhri S, Kumar S, Gupta S
Pharm Res
. 2025 Jan;
42(1):49-67.
PMID: 39775614
Metabolic alterations are commonly associated with various cancers and are recognized as contributing factors to cancer progression, invasion, and metastasis. Drug repurposing, a strategy in drug discovery, utilizes existing knowledge...
2.
Kumar S, Chaudhri S
Pathol Res Pract
. 2024 Oct;
263:155620.
PMID: 39357179
Insulin-like growth factor 1/Insulin-like growth factor 1-receptor (IGF-1/IGF-1R) pathway is highly breast cancer subtype context-dependent. Triple-negative breast cancer (TNBC) is an aggressive, highly metastatic cancer showing early recurrence and poor...
3.
Prajapati K, Gupta S, Chaudhri S, Kumar S
Exp Cell Res
. 2024 Apr;
438(1):114035.
PMID: 38593917
Members of ONECUT transcription factor play an essential role in several developmental processes, however, the atypical expression of ONECUT proteins lead to numerous diseases, including cancer. ONECUT family proteins promote...
4.
Shuaib M, Chaudhri S, Kumar S
Biomol Concepts
. 2024 Mar;
15(1).
PMID: 38525814
Triple-negative breast cancer (TNBC) is a highly metastatic subtype of breast cancer. Due to the absence of obvious therapeutic targets, microRNAs (miRNAs) provide possible hope to treat TNBC. Withaferin A...